• Call Us+91-9216325808
  • Email us bdm@dmpharmaglobal.com

Our Blogs

Home / Our Blogs
US Ties Vaccine Funding to Removal of Mercury-Based Preservatives

US Links Global Vaccine Funding to Removal of Mercury-Based Preservatives

Global immunisation efforts are facing renewed scrutiny as funding conditions increasingly influence public health […]

Read More
What Indian Biopharma Expects from Budget 2026 | Policy & Growth

What’s Indian Biopharma Betting On in Budget 2026? Policy Priorities for Future Growth

As India sets its sights on emerging as a global biopharmaceutical leader […]

Read More
India–EU Pharma Trade: Opportunities & Risks After Modi–Europe Talks

India–EU Pharma Trade After Modi–Europe Talks: Opportunities, Risks, and the Access-to-Medicines Debate

The evolving pharma trading relationship between India and Europe […]

Read More
Centre Trims Trial Burden on New Drugs | NDCT Rules Update

Centre Trims Trial Burden on New Drugs: A Big Relief for India’s Pharma Ecosystem

In a significant policy move aimed at simplifying drug development and easing regulatory pressure, the Union Health […]

Read More
Blue Strip Labeling for Antibiotics in India | AMR Control Initiative

Blue Strip Labeling for Antibiotics: A Strategic Step to Combat Antimicrobial Resistance in India

Antimicrobial Resistance (AMR) has emerged as one of the most serious public health threats in India. To address th […]

Read More
AI in Drug Development: Faster Trials & Smarter Regulatory Filings

How Artificial Intelligence Is Transforming Drug Trials and Regulatory Processes

Artificial Intelligence (AI) is steadily redefining how the pharmaceutical industry operates. While the promise of […]

Read More
US FDA Delays Fast-Track Drug Reviews Over Safety and Efficacy Concerns

US FDA Delays Fast-Track Drug Reviews Amid Safety and Efficacy Concerns

Regulatory speed and patient safety often exist in delicate balance, especially when new drug approval programs prom […]

Read More
Patent Rejection Clears Path for Affordable Cancer Medicines in India

Patent Rejection Opens the Door for Affordable Cancer Treatment in India

India’s pharmaceutical and healthcare ecosystem has once again demonstrated its strong stance on patient-centric i […]

Read More
pharma contract manufacturing WHO - GMP Certified

Which PCD Pharma Franchise Companies Have Their Own WHO-GMP Manufacturing Plants?

The Indian pharmaceutical industry is growing rapidly, and entrepreneurs are increasingly looking for reliable PCD pharma franchise companies […]

Read More
Why a Dermatology-Focused PCD Pharma Franchise is Your Fastest Path

The Hidden Goldmine: Why a Dermatology-Focused PCD Pharma Franchise is Your Fastest Path to Profit

Let’s cut through the noise. Every aspiring pharma entrepreneur is chasing the same “top 10 PCD” lists, fightin […]

Read More
Call Us Whats App Send Enquiry